Applications of PLA in modern medicine

被引：390

作者：

DeStefano V. ^{[1
]}

Khan S. ^{[1
]}

Tabada A. ^{[1
]}

机构：

[1] Department of Biomedical Engineering, Stony Brook University, Stony Brook, 11794, NY

来源：

Engineered Regeneration | 2020年 / 1卷

关键词：

Cancer therapy; Cardiovascular; Dental; Drug carriers; Orthopedics; Polylactic acid; Polymers; skin/tendon healing; surgical tools; Tissue engineering;

D O I：

10.1016/j.engreg.2020.08.002

中图分类号：

学科分类号：

摘要：

Polylactic acid (PLA) is a versatile biopolymer. PLA is synthesized with ease from abundant renewable resources and is biodegradable. PLA has shown promise as a biomaterial in a plethora of healthcare applications such as tissue engineering or regenerative medicine, cardiovascular implants, dental niches, drug carriers, orthopedic interventions, cancer therapy, skin and tendon healing, and lastly medical tools / equipment. PLA has demonstrated instrumental importance as a three-dimensionally (3D) printable biopolymer, which has further been bolstered by its role during the Coronavirus Disease of 2019 (Covid-19) global pandemic. As an abundant filament, PLA has created desperately needed personal protective equipment (PPE) and ventilator modifications. As polymer chemistry continues to advance, so too will the applications and continued efficacy of PLA-based modalities. © 2020 KeAi Communications Co., Ltd

引用

页码：76 / 87

页数：11

共 60 条

[31]

Maji R., Dey N.S., Satapathy B.S., Mukherjee B., Mondal S., Preparation and characterization of Tamoxifen citrate loaded nanoparticles for breast cancer therapy, Int. J. Nanomed., 9, pp. 3107-3118, (2014)

[32]

Hrkach J., Von Hoff D., Mukkaram Ali M., Et al., Preclinical development and clinical translation of a PSMA-targeted docetaxel nanoparticle with a differentiated pharmacological profile, Sci. Transl. Med., 4, 128, (2012)

[33]

Pawar R., Tekale S., Shisodia S., Totre J., Domb A., Biomedical applications of poly(Lactic Acid), Recent Patents on Regener. Med., (2014)

[34]

Inkinen S., Hakkarainen M., Albertsson A.C., Sodergard A., From lactic acid to poly(lactic acid) (PLA): characterization and analysis of PLA and its precursors, Biomacromolecules, 12, 3, pp. 523-532, (2011)

[35]

Narayanan G., Vernekar V.N., Kuyinu E.L., Laurencin C.T., Poly (lactic acid)-based biomaterials for orthopaedic regenerative engineering, Adv.Drug Deliv. Rev., 107, pp. 247-276, (2016)

[36]

Lv G., He F., Wang X., Et al., Novel nanocomposite of nano fe(3)o(4) and polylactide nanofibers for application in drug uptake and induction of cell death of leukemia cancer cells, Langmuir, 24, 5, pp. 2151-2156, (2008)

[37]

Zhao X., Zhao J., Lin Z.Y., Et al., Self-coated interfacial layer at organic/inorganic phase for temporally controlling dual-drug delivery from electrospun fibers, Colloids Surf B: Biointerfaces, 130, pp. 1-9, (2015)

[38]

Yuan Z., Zhao X., Zhao J., Et al., Synergistic mediation of tumor signaling pathways in hepatocellular carcinoma therapy via dual-drug-loaded pH-responsive electrospun fibrous scaffolds, J. Mater. Chem. B, 3, 17, pp. 3436-3446, (2015)

[39]

Zhao X., Yuan Z., Yildirimer L., Et al., Tumor-triggered controlled drug release from electrospun fibers using inorganic caps for inhibiting cancer relapse, Small, 11, 34, pp. 4284-4291, (2015)

[40]

Pan G., Liu S., Zhao X., Zhao J., Fan C., Cui W., Full-course inhibition of biodegradation-induced inflammation in fibrous scaffold by loading enzyme-sensitive prodrug, Biomaterials, 53, pp. 202-210, (2015)

← 1 2 3 4 5 6 →